Chemours (CC) CFO reports 47,387-share grant and 3,232-share tax withholding

Rhea-AI Filing Summary

Chemours Chief Financial Officer Shane Hostetter reported equity compensation and related tax withholding transactions in company common stock. On March 2, he acquired 47,387 shares through a grant or award at a stated price of $0.0000 per share, increasing his directly owned and unit-based holdings to 101,857.1999 shares. A related footnote states this restricted stock unit (RSU) award is scheduled to vest in three equal annual installments beginning on March 1, 2027. On March 1, 3,232 shares at $18.2400 per share were automatically withheld to satisfy tax obligations on vesting RSUs and dividend equivalent units, with the filing clarifying that no shares were sold. Following the tax-withholding disposition, his directly held total was 54,470.1999 shares, which a footnote explains includes directly owned shares, RSUs and dividend equivalent units.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider HOSTETTER SHANE

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	47,387	$0.00	--
Tax Withholding	Common Stock	3,232	$18.24	$59K

Holdings After Transaction: Common Stock — 101,857.2 shares (Direct)

Footnotes (1)

1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027. Includes directly owned shares, RSUs and dividend equivalent units.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOSTETTER SHANE

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19899

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F		3,232(1)	D	$18.24	54,470.1999	D
Common Stock	03/02/2026		A		47,387(2)	A	$0	101,857.1999(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

2. RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027.

3. Includes directly owned shares, RSUs and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Chemours (CC) CFO Shane Hostetter report?

Chemours CFO Shane Hostetter reported an equity grant of 47,387 common shares on March 2 and a related 3,232-share tax-withholding disposition on March 1. These transactions involved restricted stock units and associated tax obligations, not open-market share sales.

Was there an open-market sale of Chemours (CC) shares by the CFO?

No open-market sale occurred. The filing states 3,232 shares were automatically withheld at $18.2400 per share solely to satisfy tax obligations on vesting RSUs and dividend equivalent units. A footnote explicitly clarifies that no shares were sold in the market.

What equity award did Chemours (CC) grant to its CFO on March 2, 2026?

On March 2, Chemours granted CFO Shane Hostetter 47,387 common shares as a grant or award acquisition, recorded at $0.0000 per share. This award is tied to restricted stock units, forming part of his long-term incentive-based compensation in Chemours stock.

How will the Chemours (CC) CFO’s new RSU award vest over time?

The RSU award is scheduled to vest in three equal annual installments starting on March 1, 2027. This means one-third of the granted units will vest each year over three years, aligning compensation with multi-year company performance and continued service.

How many Chemours (CC) shares and units does the CFO hold after these transactions?

After the March 2 grant, the CFO’s total directly held and unit-based position is 101,857.1999 shares. A footnote explains this figure includes directly owned shares, restricted stock units, and dividend equivalent units, reflecting his combined equity interest in Chemours.

What does the tax-withholding disposition in the Chemours (CC) Form 4 represent?

The tax-withholding disposition of 3,232 shares at $18.2400 per share represents shares automatically withheld to cover tax obligations from vesting RSUs and dividend equivalent units. According to the footnote, this mechanism is exempt under Rule 16b-3 and did not involve a market sale.